Fulcrum Therapeutics Inc. (FULC) Tops Q1 EPS by 1c, provides guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to Fulcrum Therapeutics Inc. (FULC) Tops Q1 EPS by 1c, provides guidance

BofA Securities Reiterates Underperform Rating on Fulcrum Therapeutics (FULC)

May 14, 2024 8:47 AM EDT

BofA Securities analyst Tazeen Ahmad reiterated an Underperform rating and $5.00 price target on Fulcrum Therapeutics (NASDAQ: FULC).

The analyst comments "FULC announced the company has entered an exclusive license agreement with Sanofi (ticker: SNY; covered by Graham Perry) for the ex-US development of losmapimod in... More

Fulcrum Therapeutics (FULC) PT Raised to $22 at Stifel

May 13, 2024 12:31 PM EDT

Stifel analyst Dae Gon Ha raised the price target on Fulcrum Therapeutics (NASDAQ: FULC) to $22.00 (from $19.00) while maintaining a Buy rating.

The analyst comments "Ph.3 REACH (facioscapulohumeral muscular dystrophy [FSHD]) data in 4Q24 are the main focus for FY2024, and we're... More